A Study of Intra-operative Imaging in Women With Ovarian Cancer
NCT04878094 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 310
Last updated 2026-05-20
Summary
The purpose of this study is to find out whether using the PINPOINT imaging system intra-operatively can reduce the risk of anastomotic leaks and other complications after surgery for ovarian cancer, compared with standard intra-operative assessments alone. The PINPOINT endoscopic fluorescence imaging system uses a special camera and a fluorescent (glowing) dye that can evaluate the blood flow of the bowel in real-time. If there is an area that appears concerning, the surgeon can correct the problem during the procedure.
Conditions
- Ovarian Cancer
- Ovarian Carcinoma
Interventions
- DIAGNOSTIC_TEST
-
Intravenous Indocyanine Green/ICG injection
Intravenous Indocyanine Green/ICG injection will be administered for visualization
- DIAGNOSTIC_TEST
-
PINPOINT endoscopic fluorescence imaging system
After resection the surgeon will use the PINPOINT imaging system to assess perfusion of the colonic stump. The intervention will again be used following establishment of the anastomosis, however this time via a proctoscope to visualize the proximal and distal ends of the rectosigmoid anastomosis.
- DIAGNOSTIC_TEST
-
Endoscopy
Standard technique and assessment of anastomosis without the use of NIR angiography
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Mario Leitao, MD · Memorial Sloan Kettering Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-03
- Primary Completion
- 2027-05-03
- Completion
- 2027-05-03
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Lavage of the Uterine Cavity for Diagnosis of Ovarian Cancer
NCT03606486 ·Status: TERMINATED ·Phase: NA
-
A Multivariate Index Assay for Ovarian Cancer Risk Assessment in Women With Adnexal Mass and High-Risk Germline Variants
NCT04487405 ·Status: TERMINATED
-
Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer
NCT02317705 ·Status: COMPLETED ·Phase: PHASE2
-
Unravelling Tumour Biology In Ovarian Cancer With Precision Imaging
NCT06084195 ·Status: RECRUITING ·Phase: NA
-
A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy
NCT06240598 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Screening for Ovarian Malignancy
NCT06348784 ·Status: COMPLETED
-
Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression
NCT00659399 ·Status: WITHDRAWN ·Phase: PHASE1
-
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
NCT04794322 ·Status: RECRUITING
-
Radiolabeled Folic Acid and Imaging to Detect Ovarian Cancer
NCT00003763 ·Status: COMPLETED ·Phase: NA
-
OTL38 for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
NCT03180307 ·Status: COMPLETED ·Phase: PHASE3
-
Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging
NCT05866679 ·Status: SUSPENDED ·Phase: PHASE1
-
Adjuvant Whole Abdominal Intensity Modulated Radiotherapy (IMRT) for High Risk Stage FIGO III Patients With Ovarian Cancer
NCT00527631 ·Status: UNKNOWN ·Phase: PHASE1
-
Pembrolizumab With Chemotherapy and MK-4830 for Treating Participants With Ovarian Cancer (MK-4830-002)
NCT05446870 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
NCT00039559 ·Status: UNKNOWN ·Phase: NA
-
Ovarian Cancer Risk Estimation in Patients With Pelvic Mass
NCT00987649 ·Status: COMPLETED
-
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
NCT05047926 ·Status: COMPLETED ·Phase: NA
-
Biomarkers for Early Detection of Ovarian Cancer Using Uterine Lavage
NCT03150121 ·Status: UNKNOWN ·Phase: NA
-
EC17 for Intraoperative Imaging in Occult Ovarian Cancer
NCT02000778 ·Status: COMPLETED ·Phase: PHASE1
-
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer
NCT00072410 ·Status: COMPLETED ·Phase: PHASE1
-
Risk of Ovarian Cancer in Patients With a Pelvic Mass
NCT00315692 ·Status: COMPLETED
-
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
NCT04204811 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
OveRcoming immunosupprEssion aNd rebAlancing the Immune reSponSe in ovAriaN CancEr Study
NCT06611072 ·Status: RECRUITING ·Phase: NA
-
Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro
NCT05952453 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of Gated PET/CT in the Diagnosis of Advanced Ovarian Cancer
NCT02258165 ·Status: COMPLETED
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED